Latest filing published 20 Feb 2025 for Dynavax Technologies CORP, €50k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert Janssen: trading record in brief
This profile gathers the share dealings of Robert Janssen in Dynavax Technologies Corp, where the filings describe the role as senior executive. Between 11 March 2014 and 18 February 2025, the trades on record add up to 82 filings.
On the open market, the record shows 4 purchases worth €56k and 22 sales worth €4.8M. Taken together, the sales exceed the purchases by €4.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 19 share grants and 36 option exercises.
Half of the purchases are above €16k and half below. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 20 February 2025, reports a share grant of €50k in Dynavax Technologies Corp. The last purchase on record was published on 26 January 2017, which is 3,573 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Janssen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,041 shares@ US$12.930.7% of flowCommon StockSEC:0001029142-25-000057:1
- 11,904 sharesCommon StockSEC:0001029142-25-000057:0
- 4,614 shares@ US$12.690.8% of flowCommon StockSEC:0001029142-25-000033:1
- 13,000 sharesCommon StockSEC:0001029142-25-000033:0
- 1,781 shares@ US$13.200.3% of flowCommon StockSEC:0001029142-25-000020:1
- 4,333 sharesCommon StockSEC:0001029142-25-000020:0
- 1,531 shares@ US$12.820.2% of flowCommon StockSEC:0001209191-24-003286:1
- 4,333 sharesCommon StockSEC:0001209191-24-003286:0
- 4,043 shares@ US$12.790.7% of flowCommon StockSEC:0001209191-24-002975:1
- 10,000 sharesCommon StockSEC:0001209191-24-002975:0
- 4,043 shares@ US$10.360.5% of flowCommon StockSEC:0001209191-24-002917:1
- 10,000 sharesCommon StockSEC:0001209191-24-002917:0
- 1,500 shares@ US$15.000.3% of flowCommon StockSEC:0001209191-24-001195:1
- 1,500 shares@ US$9.410.8% of flowCommon StockSEC:0001209191-24-001195:0
- 1,755 shares@ US$9.410.9% of flowCommon StockSEC:0001209191-23-052662:0
- 1,755 shares@ US$15.010.3% of flowCommon StockSEC:0001209191-23-052662:1
- 5,015 shares@ US$15.031.0% of flowCommon StockSEC:0001209191-23-051760:1
- 5,015 shares@ US$9.412.6% of flowCommon StockSEC:0001209191-23-051760:0
- 600 shares@ US$15.020.1% of flowCommon StockSEC:0001209191-23-047434:1
- 600 shares@ US$9.410.3% of flowCommon StockSEC:0001209191-23-047434:0
- 34,857 shares@ US$15.016.5% of flowCommon StockSEC:0001209191-23-047167:1
- 34,857 shares@ US$9.4117.5% of flowCommon StockSEC:0001209191-23-047167:0
- 2,600 shares@ US$15.050.5% of flowCommon StockSEC:0001209191-23-045252:1
- 2,600 shares@ US$9.411.3% of flowCommon StockSEC:0001209191-23-045252:0
- 2,014 shares@ US$10.360.3% of flowCommon StockSEC:0001209191-23-014189:1
25 of 82 declarations